Vnitr Lek 2012, 58(Suppl 1):79-103

Revaskularizace myokardu. Perkutánní koronární intervence a aortokoronární bypass

P. Kala1,*, P. Němec2, M. Želízko3, J. Pirk3, P. Widimský4
1 Interní kardiologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Jindřich Špinar, CSc., FESC
2 Centrum kardiovaskulární a transplantační chirurgie Brno, ředitel doc. MUDr. Petr Němec, CSc.
3 Kardiocentrum Institutu klinické a experimentální medicíny Praha, přednosta prof. MUDr. Jan Pirk, DrSc.
4 Kardiocentrum III. lékařské fakulty UK a FN Královské Vinohrady Praha, přednosta prof. MUDr. Petr Widimský, DrSc., FESC

Received: December 15, 2011; Published: February 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kala P, Němec P, Želízko M, Pirk J, Widimský P. Revaskularizace myokardu. Perkutánní koronární intervence a aortokoronární bypass. Vnitr Lek. 2012;58(Supplementum 1):79-103.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006; 27: 1341-1381. Go to original source... Go to PubMed...
    2. Singh M, Rihal CS, Lennon RJ et al. Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores. Mayo Clinic Proceedings 2007; 82: 701-708. Go to original source... Go to PubMed...
    3. Singh M, Peterson ED, Milford-Beland S et al. Validation of the Mayo Clinic risk score for in-hospital mortality after percutaneous coronary interventions using the National Cardiovascular Data Registry. Circ Cardiovasc Interv 2008; 1: 36-44. Go to original source... Go to PubMed...
    4. Sianos G, Morel MA, Kappetein AP et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. Euro Interv 2005; 1: 219-227.
    5. Roques F, Michel P, Goldstone AR et al. The logistic EuroSCORE. Eur Heart J 2003; 24: 882-883. Go to original source... Go to PubMed...
    6. Roques F, Nashef SA, Michel P et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999; 15: 816-822; discussion 822-823. Go to original source... Go to PubMed...
    7. Anderson RP. First publications from the Society of Thoracic Surgeons National Database. Ann Thorac Surg 1994; 57: 6-7. Go to original source... Go to PubMed...
    8. Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 1989; 79: I3-I12.
    9. Hattler BG, Madia C, Johnson C et al. Risk stratification using the Society of thoracic surgeons programme. Ann Thorac Surg 1994; 52: 1348-1352. Go to original source... Go to PubMed...
    10. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Association for Percutaneous Cardiovascular Interventions (EAPCI). Wijns W, Kolh P, Danchin N et al. Guidelines on myocardial revascularization. Eur Heart J 2010; 31: 2501-2555.
    11. Selmer R, Halvorsen S, Linnestad K et al. Cost-effectiveness of thrombolysis versus percutaneous coronary intervention (PCI) for acute myocardial infarction. Proc One HTA Health Technol Assess Int Meet 1st 2004 Krakow Pol 2004; 1: 10.
    12. Stroupe K T, Morrison DA, Hlatky MA et al. Investigators of Veterans Affairs Cooperative Studies Program #385 (AWESOME: Angina With Extremely Serious Operative Mortality Evaluation). Cost-Effectiveness of Coronary Artery Bypass Grafts Versus Percutaneous Coronary Intervention for Revascularization of High-Risk Patients. Circulation 2006; 114: 1251-1257. Go to original source... Go to PubMed...
    13. Klein LW. Are Drug-Eluting Stents the Preferred Treatment for Multivessel Coronary Artery Disease? J Amer Coll Cardiol 2006; 47: 22-26. Go to original source... Go to PubMed...
    14. Boden WE, O'Rourke RA, Teo KK et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-1516. Go to original source... Go to PubMed...
    15. Katritsis DG, Ioannidis JP. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation 2005; 111: 2906-2912. Go to original source... Go to PubMed...
    16. Trikalinos TA, Alsheikh-Ali AA, Tatsioni A et al. Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. Lancet 2009; 373: 911-918. Go to original source... Go to PubMed...
    17. Shaw LJ, Berman DS, Maron DJ et al. COURAGE Investigators. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008; 117: 1283-1291. Go to original source... Go to PubMed...
    18. Tonino PA, De Bruyne B, Pijls NH et al. FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009; 360: 213-224. Go to original source... Go to PubMed...
    19. Pijls NH, Fearon WF, Tonino PA et al. FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 2010; 56: 177-184. Go to original source... Go to PubMed...
    20. Tonino PA, Fearon WF, De Bruyne B et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 2010; 55: 2816-2821. Go to original source... Go to PubMed...
    21. Pocock SJ, Henderson RA, Rickards AF et al. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 1995; 346: 1184-1189. Go to original source... Go to PubMed...
    22. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med 1996; 335: 217-225.
    23. Serruys PW, Unger F, Sousa JE et al. Arterial Revascularization Therapies Study Group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001; 344: 1117-1124. Go to original source... Go to PubMed...
    24. SOS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent Or Surgery trial): a randomised controlled trial. Lancet 2002; 360: 965-970. Go to original source... Go to PubMed...
    25. Hlatky MA, Boothroyd DB, Bravata DM et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009; 373: 1190-1197. Go to original source... Go to PubMed...
    26. Serryus PW, Morice MC, Kappetein AP et al. SYNTAX Investigators. Percutaneous Coronary Intervention versus Coronary Atrery Bypass Grafting for Severe Coronary Artery Disease. N Engl J Med 2009; 360: 961-972. Go to original source... Go to PubMed...
    27. Yusuf C, Zucker D, Peduzzi P et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344: 563-570. Go to original source... Go to PubMed...
    28. Jeremias A, Kaul S, Rosengart TK et al. The impact of revascularization on mortality in patients with nonacute coronary artery disease. Am J Med 2009; 122: 152-161. Go to original source... Go to PubMed...
    29. Taggart DP, D'Amico R, Altman DG. Effect of arterial revacularisation on survival: a systemic review of studies comparing bilateral and single internal mammary arteries. Lancet 2001; 358: 870-875. Go to original source... Go to PubMed...
    30. The FRISC II Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 1999; 354: 708-715. Go to original source...
    31. Fox KA, Poole-Wilson PA, Henderson RA et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 2002; 360: 743-751. Go to original source... Go to PubMed...
    32. Spacek R, Widimsky P, Straka Z et al. Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicentre randomized trial. The VINO Study. Eur Heart J 2002; 23: 230-238. Go to original source... Go to PubMed...
    33. Ottervanger JP, Armstrong P, Barnathan ES et al. GUSTO IV-ACS Investigators. Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS. Eur Heart J 2004; 25: 1494-1501. Go to original source... Go to PubMed...
    34. Hirsch A, Windhausen F, Tijssen JG et al. Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) investigators. Long-term outcome after an early invasive versus selective noninvasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study. Lancet 2007; 369: 827-835. Go to original source... Go to PubMed...
    35. Mehta SR, Cannon CP, Fox KA et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 2005; 293: 2908-2917. Go to original source... Go to PubMed...
    36. Mehta RS, Granger CB, Boden WE et al. TIMACS Investigators. Early versus Delayed Invasive Intervention in Acute Coronary Syndromes. N Engl J Med 2009; 360: 2165-2175. Go to original source... Go to PubMed...
    37. Neumann FJ, Kastrati A, Pogatsa-Murray G et al. Evaluation of prolonged antithrombotic pre treatment (cooling off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA 2003; 290: 1593-1599. Go to original source... Go to PubMed...
    38. Fox KA, Goodman SG, Anderson FA Jr et al. GRACE Investigators. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003; 24: 1414-1424. Go to original source... Go to PubMed...
    39. Bhatt DL, Roe MT, Peterson ED et al. CRUSADE Investigators. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA 2004; 292: 2096-2104. Go to original source... Go to PubMed...
    40. Grines CL, Browne KF, Marco J et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993; 328: 673-679. Go to original source... Go to PubMed...
    41. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20. Go to original source... Go to PubMed...
    42. Grines CL, Westerhausen DR Jr, Grines LL et al. Air PAMI Study Group. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study. J Am Coll Cardiol 2002; 39: 1713-1719. Go to original source... Go to PubMed...
    43. Widimsky P, Groch L, Zelizko M et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000; 21: 823-831. Go to original source... Go to PubMed...
    44. Widimsky P, Budesinsky T, Vorac D et al. 'PRAGUE' Study Group Investigators. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial - PRAGUE-2. Eur Heart J 2003; 24: 94-104. Go to original source... Go to PubMed...
    45. Andersen HR, Nielsen TT, Rasmussen K et al. DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003; 349: 733-742. Go to original source... Go to PubMed...
    46. Zijlstra F, Patel A, Jones M et al. PCAT collaboration. Clinical characteristics and outcome of patients with early (le; 2 h), intermediate (2-4 h) and late (4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J 2002; 23: 550-557. Go to original source... Go to PubMed...
    47. Bonnefoy E, Lapostolle F, Leizorovicz A et al. Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) study group. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 2002; 360: 825-829. Go to original source... Go to PubMed...
    48. Kastrati A, Mehilli J, Schlotterbeck K et al. Bavarian Reperfusion Alternatives Evaluation (BRAVE) Study Investigators. Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial. JAMA 2004; 291: 947-954. Go to original source... Go to PubMed...
    49. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 2006; 367: 569-578.
    50. Ellis SG, Tendera M, de Belder MA et al. FINESSE Investigators. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med 2008; 358: 2205-2217. Go to original source... Go to PubMed...
    51. Lee DP, Herity NA, Hiatt BL et al. TIrofiban Given in the Emergency Room before Primary Angioplasty. Adjunctive platelet glycoprotein IIb/IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: results of theTIrofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) pilot trial. Circulation 2003; 107: 1497-1501. Go to original source... Go to PubMed...
    52. Van't Hof AW, Ernst N, De Boer MJ et al. On-TIME study group. Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial. Eur Heart J 2004; 25: 837-846. Go to original source... Go to PubMed...
    53. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials. Lancet 2006; 367: 579-588. Go to original source... Go to PubMed...
    54. Ellis SG, da Silva ER, Heyndrickx G et al. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation 1994; 90: 2280-2284. Go to original source... Go to PubMed...
    55. Ellis SG, Da Silva ER, Spaulding CM et al. Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences. Am Heart J 2000; 139: 1046-1053. Go to original source... Go to PubMed...
    56. Gershlick AH, Stephens-Lloyd A, Hughes S et al. REACT Trial Investigators. Rescue Angioplasty after Failed Thrombolytic Therapy for Acute Myocardial Infarction. N Engl J Med 2005; 353: 2758-2768. Go to original source... Go to PubMed...
    57. Fernández-Avilés F, Alonso JJ, Castro-Beiras A et al. GRACIA (Grupo de Análisis de la Cardiopatía Isquémica Aguda) Group. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. Lancet 2004; 364: 1045-1053. Go to original source... Go to PubMed...
    58. Le May MR, Wells GA, Labinaz M et al. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). J Am Coll Cardiol 2005; 46: 417-424. Go to original source... Go to PubMed...
    59. Fernández-Avilés F, Alonso JJ, Pena G et al. GRACIA-2 (Groupo de Análisis de Cardiopatía Isquémica Aguda) Investigators. Primary angioplasty vs early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. Eur Heart J 2007; 28: 949-960. Go to original source... Go to PubMed...
    60. Di Mario C, Dudek D, Piscione F et al. CARESS-in-AMI (Combined Abciximab RE-teplase Stent Study in Acute Myocardial Infarction) Investigators. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab Reteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet 2008; 371: 559-568. Go to original source... Go to PubMed...
    61. Cantor WJ, Fitchett D, Borgundvaag B et al. TRANSFER-AMI Trial Investigators. Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction. N Engl J Med 2009; 360: 2705-2718. Go to original source... Go to PubMed...
    62. Yousef ZR, Redwood SR, Bucknall CA et al. Late intervention after anterior myocardial infarction: effects on left ventricular size, function, quality of life, and exercise tolerance: results of the Open Artery Trial (TOAT Study). J Am Coll Cardiol 2002; 40: 869-876. Go to original source... Go to PubMed...
    63. Steg PG, Thuaire C, Himbert D et al. DECOPI Investigators. DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multicentre trial of occluded artery angioplasty after acute myocardial infarction. Eur Heart J 2004; 25: 2187-2194. Go to original source... Go to PubMed...
    64. Hochman JS, Lamas GA, Buller CE et al. Occluded Artery Trial Investigators. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 2006; 355: 2395-2407. Go to original source... Go to PubMed...
    65. Weiss ES, Chang DD, Joyce DL et al. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data. J Thorac Cardiovasc Surg 2008; 135: 503-511. Go to original source... Go to PubMed...
    66. Lee DC, Oz MC, Weinberg AD et al. Appropriate timing of surgical intervention after transmural acute myocardial infarction. J Thorac Cardiovasc Surg 2003; 125: 115-119. Go to original source... Go to PubMed...
    67. Hochman JS, Sleeper LA, Webb JG et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999; 341: 625-634. Go to original source... Go to PubMed...
    68. Hochman JS, Sleeper LA, White HD et al. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. One-year survival following early revascularization for cardiogenic shock. JAMA 2001; 285: 190-192. Go to original source... Go to PubMed...
    69. Urban P, Stauffer JC, Bleed D et al. A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicentre Trial of Angioplasty for Shock-(S)MASH. Eur Heart J 1999; 20: 1030-1038. Go to original source... Go to PubMed...
    70. Smith PK, Califf RM, Tuttle RH et al. Selection of surgical or percutaneous coronary intervention provides differential longevity benefit. Ann Thorac Surg 2006; 82: 1420-1428. Go to original source... Go to PubMed...
    71. Allman KC, Shaw LJ, Hachamovitch R et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002; 39: 1151-1158. Go to original source... Go to PubMed...
    72. Bourque JM, Hasselblad V, Velazquez EJ et al. Revascularization in patients with coronary artery disease, left ventricular dysfunction, and viability: a meta-analysis. Am Heart J 2003; 146: 621-627. Go to original source... Go to PubMed...
    73. O'Connor CM, Velazquez EJ, Gardner LH et al. Comparison of coronary artery bypass rafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank). Am J Cardiol 2002; 90: 101-107. Go to original source... Go to PubMed...
    74. Tarakji KG, Brunken R, McCarthy PM et al. Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction. Circulation 2006; 113: 230-237. Go to original source... Go to PubMed...
    75. Tsuyuki RT, Shrive FM, Galbraith PD et al. APPROACH Investigators. Revascularization in patients with heart failure. CMAJ 2006; 175: 361-365. Go to original source... Go to PubMed...
    76. Buszman P, Szkróbka I, Gruszka A et al. Comparison of effectiveness of coronary artery bypass grafting versus percutaneous coronary intervention in patients with ischemic cardiomyopathy. Am J Cardiol 2007; 99: 36-41. Go to original source... Go to PubMed...
    77. Cannon CP, Weintraub WS, Demopoulos LA et al. TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy) - Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344: 1879-1887. Go to original source... Go to PubMed...
    78. BARI 2D Study Group. Frye RL, August P, Brooks MM et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009; 360: 2503-2515. Go to original source... Go to PubMed...
    79. Levey AS, Coresh J, Greene T et al. Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254. Go to original source... Go to PubMed...
    80. Astor BC, Coresh J, Heiss G et al. Kidney function and anemia as risk factors for coronary heart disease and mortality: The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2006; 151: 492-500. Go to original source... Go to PubMed...
    81. Jones DA, Rathod K, Guttmann O et al. Anaemia On Admission Is A Powerful Predictor For Worse Outcome In Patients Undergoing Primary Pci. J Am Coll Cardiol 2010; 56: B101. Go to original source...
    82. Mehran R, Pocock SJ, Nikolsky E et al. A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes. J Am Coll Cardiol 2010; 55: 2556-2566. Go to original source... Go to PubMed...
    83. Poldermans D, Bax JJ, Boersma E et al. Guidelines for preoperative cardiac risk assessment and perioperative cardiac management in noncardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J 2009; 30: 2769-2812.
    84. Benedetto U, Meliga G, Roscitato A et al. Does combined mitral valve surgery improve survival when compared to revascularization alone in patients with ischemic mitral regurgitation? A meta-analysis on 2 479 patients. J Cardiovasc Med 2009; 10: 109-114. Go to original source... Go to PubMed...
    85. Stamou SC, Hill PC, Dangas G et al. Stroke After Coronary Artery Bypass: Incidence, Predictors, and Clinical Outcome Stroke 2001; 32: 1508-1513. Go to original source... Go to PubMed...
    86. Trehan N, Mishra M, Sharma OP et al. Further reduction in stroke after off-pump coronary artery bypass grafting: a 10-year experience. Ann Thorac Surg 2001; 72: S1026-S1032. Go to original source... Go to PubMed...
    87. Morice MC, Serruys PW, Barragan P et al. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial. J Am Coll Cardiol 2007; 50: 1299-1304. Go to original source... Go to PubMed...
    88. Holmes DR Jr, Leon MB, Moses JW et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation 2004; 109: 634-640. Go to original source... Go to PubMed...
    89. Schampaert E, Cohen EA, Schlüter M et al. C-SIRIUS Investigators. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004; 43: 1110-1115. Go to original source... Go to PubMed...
    90. Schofer J, Schlüter M, Gershlick AH et al. E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) Lancet 2003; 362: 1093-1099. Go to original source...
    91. Grube E, Silber S, Hauptmann KE et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003; 107: 38-42. Go to original source... Go to PubMed...
    92. Stone GW, Ellis SG, Cox DA et al. TAXUS-IV Investigators. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 2004; 109: 1942-1947. Go to original source... Go to PubMed...
    93. Stone GW, Ellis SG, O'Shaughnessy CD et al. TAXUS V ISR Investigators. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA 2006; 295: 1253-1263. Go to original source... Go to PubMed...
    94. Grube E, Dawkins KD, Guagliumi G et al. TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions. Eur Heart J 2007; 28: 2578-2582. Go to original source... Go to PubMed...
    95. Pfisterer M, Brunner-La Rocca HP, Buser PT et al. BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006; 48: 2584-2591. Go to original source... Go to PubMed...
    96. Lagerqvist B, James SK, Stenestrand U et al. Long-Term Outcomes with Drug-Eluting Stents Versus Bare-Metal Stents in Sweden. N Engl J Med 2007; 356: 1009-1019. Go to original source... Go to PubMed...
    97. Spaulding C, Henry P, Teiger E et al. TYPHOON Investigators. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006; 355: 1093-1104. Go to original source... Go to PubMed...
    98. Laarman GJ, Suttorp MJ, Dirksen MT et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 2006; 355: 1105-1113. Go to original source... Go to PubMed...
    99. Svilaas T, Vlaar PJ, van der Horst IC et al. Thrombus Aspiration during Primary Percutaneous Coronary Intervention. N Engl J Med 2008; 358: 557-567. Go to original source... Go to PubMed...
    100. Møller CH, Penninga L, Wetterslev J et al. Clinical outcomes in randomized trials of off- vs on-pump coronary artery bypass surgery: systematic review with meta-analyses and trial sequential analyses. Eur Heart J 2008; 29: 2601-2616. Go to original source... Go to PubMed...
    101. Guru V, Omura J, Alghamdi AA et al. Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Circulation 2006; 114: I331-I338. Go to original source... Go to PubMed...
    102. Widimsky P, Motovská Z, Simek S et al. PRAGUE-8 Trial Investigators. Clopidogrel pretreatment in stable angina: for all patients > 6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8. Eur Heart J 2008; 29: 1495-1503. Go to original source... Go to PubMed...
    103. Montalescot G, White HD, Gallo R et al. STEEPLE Investigators. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N Engl J Med 2006; 355: 1006-1017. Go to original source... Go to PubMed...
    104. Mehta SR, Granger CB, Eikelboom JW et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. J Am Coll Cardiol 2007; 50: 1742-1751. Go to original source... Go to PubMed...
    105. Stone GW, Witzenbichler B, Guagliumi G et al. HORIZONS-AMI Trial Investigators. Bivalirudin during Primary PCI in Acute Myocardial Infarction. N Engl J Med 2008; 358: 2218-2230. Go to original source... Go to PubMed...
    106. Wiviott SD, Braunwald E, McCabe CH et al. TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007; 357: 2001-2015. Go to original source... Go to PubMed...
    107. Wallentin L, Becker RC, Budaj A et al. PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009; 361: 1045-1057. Go to original source... Go to PubMed...
    108. Mehta SR, Tanguay JF, Eikelboom JW et al. CURRENT-OASIS 7 trial investigators. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet 2010; 376: 1233-1243. Go to original source... Go to PubMed...
    109. Kastrati A, Mehilli J, Neumann FJ et al. Intracoronary Stenting and Antithrombotic: Regimen Rapid Early Action for Coronary Treatment 2 (ISAR-REACT 2) Trial Investigators. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. JAMA 2006; 295: 1531-1538. Go to original source... Go to PubMed...
    110. Boudoulas H, Snyder GL, Lewis RP et al. Safety and rationale for continuation of propranolol therapy during coronary bypass operation. Ann Thorac Surg 1978; 26: 222-227. Go to original source... Go to PubMed...
    111. Reduto LA, Berger HJ, Geha A et al. Radionuclide assessment of ventricular performance during propranolol withdrawal prior to aortocoronary bypass surgery. Am Heart J 1978; 96: 714-722. Go to original source... Go to PubMed...
    112. Gomes JA, Ip J, Santoni-Rugiu F et al. Oral d, I sotalol reduces the incidence of postoperative atrial fibrilation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999; 34: 334-339. Go to original source... Go to PubMed...
    113. Davis EM, Packard KA, Hilleman DE. Pharmacologic prophylaxis of postoperative atrial fibrillation in patients undergoing cardiac surgery: beyond beta-blockers. Pharmacotherapy 2010; 30: 749, 274e-318e. Go to original source... Go to PubMed...
    114. Kim DH, Daskalakis C, Silvestry SC et al. Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg 2009; 138: 1377-1384. Go to original source... Go to PubMed...
    115. Pirk J, Vojáček J, Kováč J et al. Improved patency of the aortocoronary bypass by antithrombotic drugs. Ann Thorac Surg 1986; 42: 378-381. Go to original source... Go to PubMed...
    116. Dunning J, Versteegh M, Fabbri A et al. EACTS Audit and Guidelines Committee. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 2008; 34: 73-92. Go to original source... Go to PubMed...
    117. Chassot PG, Delabays A, Spahn DR. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 2007; 99: 316-328. Go to original source... Go to PubMed...
    118. Weinmann EE, Chayen D, Kobzantzev ZV et al. Treatment of postcatheterisation false aneurysms: ultrasound-guided compression vs ultrasound-guided thrombin injection. Eur J Vasc Endovasc Surg 2002; 23: 68-72. Go to original source... Go to PubMed...
    119. Asif A, Epstein M. Prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 2004; 44: 12. Go to original source... Go to PubMed...
    120. McCullough PA. Contrast-Induced Acute Kidney Injury. J Am Coll Cardiol 2008; 51: 1419-1428. Go to original source... Go to PubMed...
    121. Weisbord SD, Hartwig KC, Sonel AF et al. The incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography. Catheter Cardiovasc Interv 2008; 71: 879-885. Go to original source... Go to PubMed...
    122. Recio-Mayoral A, Chaparro M, Prado B et al. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention - the RENO study. J Am Coll Cardiol 2007; 49: 1283-1288. Go to original source... Go to PubMed...
    123. Rudnick MR, Tumlin JA. Prevention of radiocontrast media-induced acute kidney injury. UpToDate in Nephrology and Hypertension. www.uptodate.com (last update Oct 16, 2008).
    124. Mueller C, Buerkle G, Buettner HJ et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regiments in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329. Go to original source... Go to PubMed...
    125. Kačer P, Smetana M, Pirk J et al. 64multislice CT - roční zkušenost v detekci časného uzávěru štěpů po aortokoronární rekonstrukci. Cor et Vasa v tisku.
    126. Hejjel L, Szluka G, Göbölös L et al. Pharmacotechnological pitfalls of primic - possible source of microembolization during open heart Sumery. Perfusion 2010; 25: 2067-2651. Go to original source... Go to PubMed...
    127. Dominik J. Kardiochirurgie. 1. vyd. Praha: Grada Publishing 1998.
    128. Kurusz M, Conti VR, Arens JF et al. Perfusion accident surfy. Proc Am Acad Cardiovasc Perfusion 1986; 7: 57-64.
    129. Kaplan JA. Management of coagulation and bleeding disorders. In: Kaplan JA (ed.). Cardiac anesthesia. 3rd ed. Philadelphia, PA: W. B. Saunders Company 1997: 951.
    130. Čoček D, Pirk J. Méně invazivní odběr žilního štěpu ke koronárnímu bypassu. Cor et Vasa 2000; 42: 397-400.
    131. Varga M, Matia I, Kučera M et al. Akutní uzávěr splanchnického řečiště po kardiochirurgických výkonech. Cor et Vasa 2010; 52: 252-256. Go to original source...
    132. Hradec J, Bultas J, Želízko M. Stabilní angina pectoris - Doporučený diagnostický a lečebný postup Česke kardiologicke společnosti. Cor Vasa 2010; 52: 543-561. Go to original source...
    133. Widimský P, Hlinomaz O, Kala P et al. Diagnostika a léčba akutního infarktu myokardu s elevacemi ST. Cor Vasa 2009; 51: 724-740. Go to original source...
    134. Bělohlávek J, Aschermann M. Doporučený postup pro diagnostiku a léčbu akutních koronárních syndromů bez elevací ST úseků na EKG. Cor Vasa 2008; 50 (Suppl): 1S7-1S23.
    135. De Werf FV, Bax J, Betriu A et al. ESC Committee for Practice Guidelines (CPG). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29: 2909-2945. Go to original source... Go to PubMed...
    136. Bassand JP, Hamm CW, Ardissino D et al. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007; 28: 1598-1660. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.